EDGAR Filing Documents for 0000320017-15-000053

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0000320017-15-000053

Filing Date

2015-07-15

Accepted

2015-07-14 17:41:18

Documents

Effectiveness Date

2015-07-15

Document Format Files

Seq	Description	Document	Type	Size
1	S-8	s-8july2015ecp.htm	S-8	96746
2	EXHIBIT 5.1	exhibit51paulhastingsconse.htm	EX-5.1	17652
3	EXHIBIT 23.1	exhibit231grantthorntoncon.htm	EX-23.1	3051
	Complete submission text file	0000320017-15-000053.txt		118771

Mailing Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170

Business Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170 212-584-4171

Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)